Internal Medicine · El Centro, CA
NPI
1013154400
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1600 S. Imperial Ave, Ste #3
El Centro, CA, 92243
Phone (760) 339-2802
Groups this clinician bills Medicare through
Medicare paid, 2024
$786K
64,437 services
Medicare patients, 2024
954
Average age 74
Drug cost, 2024
$2.6M
17,581 prescriptions
Company payments, 2025
$739
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alidad M Zadeh was code J3121 (injection, testosterone enanthate, 1 mg), 24,200 times for 12 patients. In total Alidad M Zadeh billed 64,437 services in 101 codes, and Medicare paid $786K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3121 Injection, testosterone enanthate, 1 mg | Office | 24,200 | 12 | $0.03 | $831 |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 23,202 | 15 | $0.02 | $519 |
| 99213 Office E&M - Established | Office | 2,163 | 697 | $70.82 | $153K |
| 96372 Injection Administration | Office | 2,107 | 251 | $10.89 | $23K |
| 99214 Office E&M - Established | Office | 1,966 | 642 | $96.88 | $190K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,521 | 188 | $0.92 | $1,405 |
| 99457 E&M - Miscellaneous | Office | 1,147 | 252 | $36.56 | $42K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 980 | 229 | $50.43 | $49K |
| 99215 Office E&M - Established | Office | 563 | 345 | $138.92 | $78K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 531 | 336 | $12.17 | $6,463 |
| 99497 Care Management/Coordination | Office | 526 | 508 | $79.10 | $42K |
| 99458 E&M - Miscellaneous | Office | 492 | 158 | $31.65 | $16K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 490 | 490 | $19.49 | $9,549 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 484 | 484 | $131.50 | $64K |
| 99454 E&M - Miscellaneous | Office | 457 | 134 | $37.58 | $17K |
By year: 2022 $1.1M for 60,213 services; 2023 $890K for 57,879 services; 2024 $786K for 64,437 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 291 | 233 | $9.45 | $2,751 |
| 82947 Clinical Chemistry | 276 | 169 | $3.76 | $1,039 |
| 81003 Clinical Chemistry | 259 | 157 | $2.18 | $565 |
| 82570 Clinical Chemistry | 146 | 131 | $5.05 | $738 |
| 0241U Infectious Agent Detection by DNA/RNA | 120 | 95 | $138.74 | $17K |
| 82043 Clinical Chemistry | 103 | 95 | $5.62 | $578 |
| 82044 Clinical Chemistry | 42 | 41 | $6.11 | $257 |
| 87635 COVID Specific | 18 | 18 | $50.28 | $905 |
| 87811 Immunoassay | 15 | 15 | $40.55 | $608 |
| 82948 Clinical Chemistry | 14 | 12 | $4.32 | $60.54 |
Medicare prescription drug claims, 2024
In 2024, the drug Alidad M Zadeh prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,135 prescriptions and refills. In total Alidad M Zadeh wrote 17,581 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,135 | 2,602 | 386 | $22K |
| Amlodipine Besylate Generic | 722 | 1,641 | 244 | $5,212 |
| Levothyroxine Sodium Generic | 649 | 1,464 | 194 | $9,129 |
| Metformin Hcl Generic | 561 | 1,330 | 197 | $5,736 |
| Ozempic Semaglutide | 540 | 708 | 142 | $575K |
| Alendronate Sodium Generic | 468 | 942 | 148 | $4,509 |
| Omeprazole Generic | 430 | 1,000 | 159 | $5,194 |
| Lisinopril Generic | 429 | 973 | 135 | $3,234 |
| Metoprolol Succinate Generic | 412 | 937 | 139 | $8,150 |
| Gabapentin Generic | 388 | 797 | 134 | $5,068 |
| Losartan Potassium Generic | 371 | 898 | 146 | $5,035 |
| Tamsulosin Hcl Generic | 331 | 707 | 113 | $6,024 |
| Atorvastatin Calcium Generic | 313 | 674 | 113 | $3,824 |
| Olmesartan Medoxomil Generic | 283 | 617 | 94 | $6,000 |
| Furosemide Generic | 255 | 508 | 104 | $1,275 |
Brand drugs: 2,962 claims; generic drugs: 14,434 claims; opioid claims: 375.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alidad M Zadeh $739 ($739 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $482.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $482 |
| Amgen Inc. AMGN | 2 | $38.7 |
| Lilly USA, LLC LLY | 2 | $31.23 |
| Merck Sharp & Dohme LLC MRK | 1 | $23.76 |
| Abbott Laboratories ABT | 1 | $22.96 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $21.1 |
| Radius Health, Inc. | 1 | $20.59 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $19.24 |
| Seqirus USA Inc CSL.AX | 1 | $18.73 |
| Pfizer Inc. PFE | 1 | $18.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.